202 related articles for article (PubMed ID: 15936846)
21. Increased expression of inhibitor of apoptosis proteins, survivin and XIAP, in non-small cell lung carcinoma.
Krepela E; Dankova P; Moravcikova E; Krepelova A; Prochazka J; Cermak J; Schützner J; Zatloukal P; Benkova K
Int J Oncol; 2009 Dec; 35(6):1449-62. PubMed ID: 19885569
[TBL] [Abstract][Full Text] [Related]
22. Co-expression patterns of tumor-associated antigen genes by non-small cell lung carcinomas: implications for immunotherapy.
Karanikas V; Tsochas S; Boukas K; Kerenidi T; Nakou M; Dahabreh J; Poularakis T; Gourgoulianis KI; Germenis AE
Cancer Biol Ther; 2008 Mar; 7(3):345-52. PubMed ID: 18094614
[TBL] [Abstract][Full Text] [Related]
23. E2F1 overexpression correlates with thymidylate synthase and survivin gene expressions and tumor proliferation in non small-cell lung cancer.
Huang CL; Liu D; Nakano J; Yokomise H; Ueno M; Kadota K; Wada H
Clin Cancer Res; 2007 Dec; 13(23):6938-46. PubMed ID: 18056168
[TBL] [Abstract][Full Text] [Related]
24. Survivin antiapoptotic gene expression as a prognostic factor in non-small cell lung cancer: in situ hybridization study.
Karczmarek-Borowska B; Filip A; Wojcierowski J; Smoleń A; Pilecka I; Jabłonka A
Folia Histochem Cytobiol; 2005; 43(4):237-42. PubMed ID: 16382892
[TBL] [Abstract][Full Text] [Related]
25. [Expression of survivin and proliferating cell nuclear antigen in human non-small cell lung cancer].
Zhou JM; Zhou JH; Deng ZH; Zheng H; Jiang HY; Cao HQ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 30(5):544-8. PubMed ID: 16320585
[TBL] [Abstract][Full Text] [Related]
26. Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer.
Végran F; Boidot R; Oudin C; Defrain C; Rebucci M; Lizard-Nacol S
Oncogene; 2007 Jan; 26(2):290-7. PubMed ID: 16847456
[TBL] [Abstract][Full Text] [Related]
27. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker.
Nouraee N; Mowla SJ; Ozhand A; Parvin M; Ziaee SA; Hatefi N
Urol J; 2009; 6(2):101-8. PubMed ID: 19472128
[TBL] [Abstract][Full Text] [Related]
28. The oncoprotein SF2/ASF promotes non-small cell lung cancer survival by enhancing survivin expression.
Ezponda T; Pajares MJ; Agorreta J; Echeveste JI; López-Picazo JM; Torre W; Pio R; Montuenga LM
Clin Cancer Res; 2010 Aug; 16(16):4113-25. PubMed ID: 20682707
[TBL] [Abstract][Full Text] [Related]
29. Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin.
Yonesaka K; Tamura K; Kurata T; Satoh T; Ikeda M; Fukuoka M; Nakagawa K
Int J Cancer; 2006 Feb; 118(4):812-20. PubMed ID: 16108013
[TBL] [Abstract][Full Text] [Related]
30. Synergistic induction of apoptosis by sulindac and arsenic trioxide in human lung cancer A549 cells via reactive oxygen species-dependent down-regulation of survivin.
Jin HO; Yoon SI; Seo SK; Lee HC; Woo SH; Yoo DH; Lee SJ; Choe TB; An S; Kwon TJ; Kim JI; Park MJ; Hong SI; Park IC; Rhee CH
Biochem Pharmacol; 2006 Nov; 72(10):1228-36. PubMed ID: 16950207
[TBL] [Abstract][Full Text] [Related]
31. Up-regulation of survivin mRNA might be a marker for non-invasive detection of non-small cell lung cancer rather than for prognosis.
Warnecke-Eberz U; Baldus SE; Bollschweiler E; Hoelscher AH; Metzger R
Anticancer Res; 2008; 28(3A):1525-9. PubMed ID: 18630507
[TBL] [Abstract][Full Text] [Related]
32. Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer.
Krysan K; Dalwadi H; Sharma S; Põld M; Dubinett S
Cancer Res; 2004 Sep; 64(18):6359-62. PubMed ID: 15374938
[TBL] [Abstract][Full Text] [Related]
33. Validation of a real-time quantitative polymerase chain reaction method for the quantification of 3 survivin transcripts and evaluation in breast cancer tissues.
Pavlidou A; Kroupis C; Goutas N; Dalamaga M; Dimas K
Clin Breast Cancer; 2014 Apr; 14(2):122-31. PubMed ID: 24325949
[TBL] [Abstract][Full Text] [Related]
34. Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancer.
Ryan B; O'Donovan N; Browne B; O'Shea C; Crown J; Hill AD; McDermott E; O'Higgins N; Duffy MJ
Br J Cancer; 2005 Jan; 92(1):120-4. PubMed ID: 15611790
[TBL] [Abstract][Full Text] [Related]
35. An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin.
Hirohashi Y; Torigoe T; Maeda A; Nabeta Y; Kamiguchi K; Sato T; Yoda J; Ikeda H; Hirata K; Yamanaka N; Sato N
Clin Cancer Res; 2002 Jun; 8(6):1731-9. PubMed ID: 12060610
[TBL] [Abstract][Full Text] [Related]
36. Tumor specific expression of survivin-2B in lung cancer as a novel target of immunotherapy.
Ichiki Y; Hanagiri T; Takenoyama M; Baba T; Fukuyama T; Nagata Y; Mizukami M; So T; Sugaya M; Yasuda M; So T; Sugio K; Yasumoto K
Lung Cancer; 2005 May; 48(2):281-9. PubMed ID: 15829330
[TBL] [Abstract][Full Text] [Related]
37. Silencing survivin expression inhibits the tumor growth of non-small-cell lung cancer cells in vitro and in vivo.
Zhang K; Li Y; Liu W; Gao X; Zhang K
Mol Med Rep; 2015 Jan; 11(1):639-44. PubMed ID: 25333812
[TBL] [Abstract][Full Text] [Related]
38. [Increase of BIRC5 gene expression in non-small cell lung cancer and esophageal squamous cell carcinoma does not correlate with expression of genes SMAC/DIABLO and PML encoding its inhibitors].
Vaĭshlia NA; Zinov'eva MV; Sass AV; Kopantsev EP; Vinogradova TV; Sverdlov ED
Mol Biol (Mosk); 2008; 42(4):652-61. PubMed ID: 18856066
[TBL] [Abstract][Full Text] [Related]
39. Inhibitors of apoptosis proteins in human cervical cancer.
Espinosa M; Cantú D; Herrera N; Lopez CM; De la Garza JG; Maldonado V; Melendez-Zajgla J
BMC Cancer; 2006 Feb; 6():45. PubMed ID: 16504151
[TBL] [Abstract][Full Text] [Related]
40. Transcriptional expression of survivin and its splice variants in brain tumors in humans.
Yamada Y; Kuroiwa T; Nakagawa T; Kajimoto Y; Dohi T; Azuma H; Tsuji M; Kami K; Miyatake S
J Neurosurg; 2003 Oct; 99(4):738-45. PubMed ID: 14567610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]